Warning letter
Avella of Deer Valley, Inc.: warning letter of Jan 17, 2014
FDA warning letter 396451 · Los Angeles District Office
Key facts
| Reference number | 396451 |
|---|---|
| Company | Avella of Deer Valley, Inc. |
| Subject | CGMP/Finished Pharmaceuticals/Adulterated/Misbranded |
| Issue date | Jan 17, 2014 |
| Posted date | Jan 27, 2014 |
| Issuing office | Los Angeles District Office |
| Product type | Drugs |
| CFR sections cited | 201.115, 211, 211.28(a), 211.42(c)(10)(iv), 211.113(b) |
| Inspection city | Phoenix |
| Inspection ZIP | 85085 |
| Inspection start date | Feb 19, 2013 |
| Letter on fda.gov | web.archive.org |
At a glance
- 1–9 CFR sections cited
- OAI Linked inspection classification
- Yes Form FDA 483 issued
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: